1 / 6

Pharmacovigilance Market to grow at 10% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2hbc1nD <br>Major industry players in pharmacovigilance market include Boehringer Ingelheim, Accenture, Bristol-Myers Squibb, Covance, ICON, PAREXEL, Quintiles, United BioSource, Synowlwedge and Cognizant Technology Solutions Corporation.

jueekate
Download Presentation

Pharmacovigilance Market to grow at 10% CAGR from 2017 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacovigilance Market Analysis, Industry Trends, Research Report 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. KeyInsights from Pharmacovigilance Market: • Increasing adverse drug reactions across the globe will fuel need for pharmacovigilance services escalating pharmacovigilance market growth over forecast timeframe. • Adverse drug reactions are among the common causes of death and morbidity within hospital settings. • Pharmacovigilance Market size is set to exceed USD 8 billion by 2024; according to a new research report by Global Market Insights. • Personalized medicine industry has witnessed rapid growth due to increased usage and acceptance in the field of cancer therapeutics. • Regulatory authorities relentless efforts to bring harmonization in pharmacovigilance practices will impact the industry growth. • Phase III trial is estimated to grow at highest CAGR from 2017 to 2024 as compared to other clinical trial segments.

  3. Continued... • Phase IV trial segment dominated pharmacovigilance market and trend is likely to continue in forthcoming years due to rising awareness and favorable regulations pertaining to post marketing surveillance. • However, state of art infrastructure and skilled staff required for in house pharmacovigilance is difficult to maintain and comes with the additional operational cost. • Japan dominated Asia Pacific pharmacovigilance market due to robust adverse drug reaction reporting system and healthcare infrastructure. • India has well established presence of many industry players including TCS, Cognizant and more. • Some of the key industry players operating in global Pharmacovigilance market are Accenture, Boehringer Ingelheim, Bristol-Myers Squibb, Cognizant Technology Solutions Corporation, F. Hoffmann-La Roche, GlaxoSmithKline, IQVIA (QuintilesIMS), IBM Corporation, Infosys, Janssen Research & Development, Ipca Laboratories, ITclinical, Laboratory Corporation of America Holdings, Novartis AG, Pfizer, Sanofi Aventis, TCS, and Wipro.

  4. India Pharmacovigilance Market, By Clinical Trial Phase, 2012 - 2024

  5. Browse Full Market Research Report On Pharmacovigilance Market @https://bit.ly/2i8RiRE Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/853https://www.gminsights.com/request-sample/detail/49

  6. Stay In Touch Website: www.gminsights.com Social Media:

More Related